Search Results - "Castillo, Dan Ran"
-
1
Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia
Published in Hematology (Luxembourg) (01-12-2023)“…T-prolymphocytic leukemia (T-PLL) is an aggressive hematologic malignancy. A portion of patients can be cured with alemtuzumab induction followed by allogeneic…”
Get full text
Journal Article -
2
Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature
Published in Pathology oncology research (25-08-2022)“…Mantle cell lymphoma (MCL) is a rare and aggressive non-Hodgkin’s B cell lymphoma characterized by the translocation t(11;14) (q13;32) and overexpression of…”
Get full text
Journal Article -
3
An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease
Published in Hematology (Luxembourg) (01-12-2023)“…Sickle cell disease (SCD) is characterized by a mutation in the beta-globin gene resulting in abnormal hemoglobin S (HgbS). The significant sequela of SCD…”
Get full text
Journal Article -
4
Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Published in Hematology reports (20-03-2022)“…Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm (MPN) that accounts for 10% of pregnancy-associated leukemias. The Philadelphia…”
Get full text
Journal Article -
5
Successful Treatment of Autoimmune Hemolytic Anemia Concomitant with Proliferation of Epstein-Barr Virus in a Post-Heart Transplant Patient
Published in Hematology reports (01-09-2022)“…Autoimmune hemolytic anemia (AIHA) is a rare complication following heart transplantation and has been attributed to several etiologies including infections,…”
Get full text
Journal Article -
6
Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products
Published in Biomedicines (14-06-2022)“…The tumor microenvironment (TME) plays an essential role in the development, proliferation, and survival of leukemic blasts in acute myeloid leukemia (AML)…”
Get full text
Journal Article -
7
Biomarker evolution after neoadjuvant systemic therapy in breast cancer
Published in Journal of clinical oncology (01-06-2022)“…e12615 Background: Tumor heterogeneity is one of the hallmarks of breast cancer (BC) and has major implications for treatment response and resistance…”
Get full text
Journal Article -
8
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer
Published in Journal of clinical oncology (01-06-2023)“…3139 Background: Breast cancer (BC) is a malignancy with a wide array of histopathological characteristics and tumor heterogeneity leading to major clinical…”
Get full text
Journal Article -
9
LUNG AS THE PRIMARY SOURCE OF INTRAVASCULAR LARGE B CELL LYMPHOMA: A DIAGNOSTIC CHALLENGE
Published in Chest (01-10-2020)Get full text
Journal Article -
10
A pilot study of intraneural facilitation versus standard physical therapy for prevention of chemotherapy-induced peripheral neuropathy
Published in Journal of clinical oncology (01-06-2023)“…12068 Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect necessitating chemotherapy (CT) dose adjustments or early…”
Get full text
Journal Article -
11
Analysis of hospitalizations of patients with Kaposi sarcoma: A national population-based study
Published in Journal of clinical oncology (01-06-2023)“…e18821 Background: Kaposi sarcoma (KS) is a type of soft tissue sarcoma due to infection with human herpes virus 8 (HHV-8) and can be associated with acquired…”
Get full text
Journal Article -
12
Analysis of hospitalizations of patients with penile cancer: A national population-based study
Published in Journal of clinical oncology (01-06-2023)“…e17033 Background: Penile cancer (PC) is a rare malignancy that is more common in developing countries. However, recent studies have shown rising…”
Get full text
Journal Article -
13
ATRIO-ESOPHAGEAL FISTULA: A RARE AND GRAVE COMPLICATION OF ATRIAL FIBRILLATION ABLATION
Published in Chest (01-10-2019)Get full text
Journal Article -
14
UTILITY OF IMMUNOHISTOCHEMISTRY IN PLEURA-BASED LUNG CANCERS: A DIAGNOSTIC DILEMMA
Published in Chest (01-10-2019)Get full text
Journal Article -
15
Unveiling the prognostic significance of BCL6+/CD10+ mantle cell lymphoma: A systematic analysis
Published in Journal of clinical oncology (01-06-2023)“…7572 Background: Mantle cell lymphoma (MCL) is heterogenetic B-cell neoplasm that characterized by the presence of the IgH/CCND1 translocation. The…”
Get full text
Journal Article -
16
Role of Ketamine and Opioid Rotation in the Management of Opioid Induced Hyperalgesia in a Patient With Acute Promyelocytic Leukemia
Published in Journal of oncology pharmacy practice (01-07-2022)“…Introduction Opioid analgesics are commonly used to manage moderate to severe cancer related pain. However long-term use of opioids has been known to lead to…”
Get full text
Journal Article -
17
Smoking and COVID-19 in patients with cancer: Novel analysis from CCC19 registry
Published in Journal of clinical oncology (01-06-2022)“…e18766 Background: Patients (pts) with thoracic cancers have a high rate of hospitalization and death from COVID-19. Smoking has been associated with increased…”
Get full text
Journal Article -
18
SAT-680 Diabetes Mellitus Induced by Programmed Cell Death-1 (PD-1) Inhibitors: A Case Report
Published in Journal of the Endocrine Society (08-05-2020)“…Introduction: Immune checkpoint blockade has revealed a remarkable success in the treatment of a range of cancer types. Immune-related adverse events on the…”
Get full text
Journal Article -
19
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
Published in Clinical lung cancer (01-07-2024)“…•Patients with thoracic cancers and COVID-19 have high mortality and morbidity.•Systematic data evaluating the impact of recent anti-cancer therapies on…”
Get full text
Journal Article -
20
Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib: A case report and literature review
Published in Journal of oncology pharmacy practice (01-12-2022)“…Introduction Thyroid carcinoma is the most common endocrine neoplasm. Multimodal therapy including surgery, radioactive iodine (RAI) therapy, and indefinite…”
Get full text
Journal Article